NO20030498L - Partikkelformig sammensetning av eletriptan som viser et sigmoidalt mönstermed kontrollert frigjöring - Google Patents

Partikkelformig sammensetning av eletriptan som viser et sigmoidalt mönstermed kontrollert frigjöring

Info

Publication number
NO20030498L
NO20030498L NO20030498A NO20030498A NO20030498L NO 20030498 L NO20030498 L NO 20030498L NO 20030498 A NO20030498 A NO 20030498A NO 20030498 A NO20030498 A NO 20030498A NO 20030498 L NO20030498 L NO 20030498L
Authority
NO
Norway
Prior art keywords
eletriptan
showing
controlled release
particle composition
sigmoidal pattern
Prior art date
Application number
NO20030498A
Other languages
English (en)
Other versions
NO20030498D0 (no
Inventor
Manaud Pierre Frederic Raspide
Ross James Macrae
Mathias Walther
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO20030498L publication Critical patent/NO20030498L/no
Publication of NO20030498D0 publication Critical patent/NO20030498D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
NO20030498A 2000-08-02 2003-01-31 Partikkelformig sammensetning av eletriptan som viser et sigmoidalt mönstermed kontrollert frigjöring NO20030498D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0018968.8A GB0018968D0 (en) 2000-08-02 2000-08-02 Particulate composition
PCT/IB2001/001279 WO2002009675A1 (en) 2000-08-02 2001-07-18 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release

Publications (2)

Publication Number Publication Date
NO20030498L true NO20030498L (no) 2003-01-31
NO20030498D0 NO20030498D0 (no) 2003-01-31

Family

ID=9896843

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030498A NO20030498D0 (no) 2000-08-02 2003-01-31 Partikkelformig sammensetning av eletriptan som viser et sigmoidalt mönstermed kontrollert frigjöring

Country Status (39)

Country Link
US (1) US20020034545A1 (no)
EP (1) EP1365748B1 (no)
JP (1) JP2004505034A (no)
KR (1) KR20030024820A (no)
CN (1) CN1630511A (no)
AP (1) AP2001002233A0 (no)
AR (1) AR030099A1 (no)
AT (1) ATE308978T1 (no)
AU (1) AU2001270932A1 (no)
BG (1) BG107361A (no)
BR (1) BR0112839A (no)
CA (1) CA2417887C (no)
CZ (1) CZ2003241A3 (no)
DE (1) DE60114887T2 (no)
EA (1) EA200300110A1 (no)
EC (1) ECSP034451A (no)
EE (1) EE200300051A (no)
ES (1) ES2250429T3 (no)
GB (1) GB0018968D0 (no)
GT (1) GT200100149A (no)
HR (1) HRP20030036A2 (no)
HU (1) HUP0301453A2 (no)
IL (1) IL153494A0 (no)
IS (1) IS6649A (no)
MA (1) MA26934A1 (no)
MX (1) MXPA03000999A (no)
NO (1) NO20030498D0 (no)
NZ (1) NZ522976A (no)
OA (1) OA12348A (no)
PA (1) PA8523101A1 (no)
PE (1) PE20020385A1 (no)
PL (1) PL359847A1 (no)
PY (1) PY0117547A (no)
SK (1) SK1082003A3 (no)
SV (1) SV2002000574A (no)
TN (1) TNSN01115A1 (no)
UY (1) UY26861A1 (no)
WO (1) WO2002009675A1 (no)
ZA (1) ZA200300868B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040022853A1 (en) * 2001-04-26 2004-02-05 Control Delivery Systems, Inc. Polymer-based, sustained release drug delivery system
AU2003294520A1 (en) * 2002-12-16 2004-07-09 Chx Technologies, Inc. Temporary, pharmacologically-inactive dental coating for the in situ protection of dental therapeutic agents from saliva and abrasion from chewing
JP2006522790A (ja) * 2003-04-11 2006-10-05 ファイザー・インク エレトリプタンと重炭酸ナトリウムを含む医薬組み合わせ物
GB2407498B (en) * 2003-10-30 2008-06-11 Cipla Ltd Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient
WO2005120456A2 (en) * 2004-06-09 2005-12-22 Pfizer Limited Formulation of eletriptan
WO2006013431A1 (en) * 2004-07-29 2006-02-09 Pfizer Limited Stable controlled-release pharmaceutical formulation of eletriptan
KR20070115918A (ko) * 2005-01-31 2007-12-06 교린 세이야꾸 가부시키 가이샤 멀티플 유닛형 경구 서방성 제제 및 그 제조방법
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
US20080226715A1 (en) * 2007-03-16 2008-09-18 Albert Cha Therapeutic compositions and methods
WO2009015336A2 (en) 2007-07-25 2009-01-29 Biolex Therapeutics, Inc. Controlled release interferon drug products and treatment of hcv infection using same
US9284416B2 (en) 2009-11-16 2016-03-15 Evonik Roehm Gmbh Process for converting a solid (meth)acrylate copolymer into a dispersed form by means of a dispersing agent
DE202015006313U1 (de) * 2014-09-09 2016-02-02 Charleston Laboratories, Inc. Pharmazeutische Zusammensetzungen
GB201716716D0 (en) * 2017-10-12 2017-11-29 Univ Of Hertfordshire Higher Education Corporation Method for coating particles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5411745A (en) * 1994-05-25 1995-05-02 Euro-Celtique, S.A. Powder-layered morphine sulfate formulations
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
GB9922963D0 (en) * 1999-09-28 1999-12-01 Pfizer Ltd Polymorphic salt
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release

Also Published As

Publication number Publication date
DE60114887T2 (de) 2006-07-20
WO2002009675A1 (en) 2002-02-07
HRP20030036A2 (en) 2003-04-30
GT200100149A (es) 2002-06-25
UY26861A1 (es) 2002-02-28
CA2417887C (en) 2006-11-14
BR0112839A (pt) 2003-06-24
PA8523101A1 (es) 2002-08-26
IS6649A (is) 2002-12-05
DE60114887D1 (de) 2005-12-15
CA2417887A1 (en) 2002-02-07
PE20020385A1 (es) 2002-05-11
US20020034545A1 (en) 2002-03-21
SK1082003A3 (en) 2004-09-08
IL153494A0 (en) 2003-07-06
JP2004505034A (ja) 2004-02-19
EP1365748A2 (en) 2003-12-03
TNSN01115A1 (fr) 2005-11-10
ZA200300868B (en) 2004-04-16
ES2250429T3 (es) 2006-04-16
GB0018968D0 (en) 2000-09-20
EE200300051A (et) 2004-10-15
KR20030024820A (ko) 2003-03-26
SV2002000574A (es) 2002-12-02
WO2002009675A9 (en) 2003-09-18
ATE308978T1 (de) 2005-11-15
AR030099A1 (es) 2003-08-13
MXPA03000999A (es) 2003-06-09
OA12348A (en) 2004-03-19
BG107361A (bg) 2003-06-30
EP1365748B1 (en) 2005-11-09
ECSP034451A (es) 2003-03-10
NZ522976A (en) 2004-11-26
HUP0301453A2 (hu) 2003-08-28
EA200300110A1 (ru) 2003-06-26
AU2001270932A1 (en) 2002-02-13
AP2001002233A0 (en) 2001-09-30
CN1630511A (zh) 2005-06-22
NO20030498D0 (no) 2003-01-31
MA26934A1 (fr) 2004-12-20
CZ2003241A3 (cs) 2004-02-18
PL359847A1 (pl) 2004-09-06
PY0117547A (es) 2003-11-03

Similar Documents

Publication Publication Date Title
NO20030498L (no) Partikkelformig sammensetning av eletriptan som viser et sigmoidalt mönstermed kontrollert frigjöring
EP1126826A4 (en) MULTIPARTIC COMPOSITION WITH MODIFIED RELEASE
EP1125586A4 (en) EXTENDED RELEASE PARTICLE
ATE441404T1 (de) Orale dosiszusammensetzung mit verlängerter freigabe
EE200300287A (et) Modifitseeritud anorgaanilised osakesed
ATE252386T1 (de) Galantamin-zusammensetzung mit gesteuerter freisetzung
NO20032561L (no) Enhetlig fordelingssjikt
ATE376582T1 (de) Zusammensetzungen mit photolabilen parfümfreisetzungssystemen
FR2837100B1 (fr) Comprimes a bases de microcapsules a liberation modifiee
EP1793809A4 (en) DOSAGE FOR IBUPROPS WITH MODIFIED RELEASE
DE60124976D1 (de) Modularer Bremsmechanismus
DE60043447D1 (de) Zusammensetzungen mit kontrollierter freigabe enthaltend nimesulid
DE60134106D1 (de) Elektrostatischgesteuerte Vorrichtungen
DE60009106D1 (de) Mikrokapseln mit veränderlicher freisetzung
DE60016836D1 (de) Resistzusammensetzung
DE60003873D1 (de) Resistzusammensetzungen und Strukturierungsverfahren
DE60122229D1 (de) Trennfilm
FI20000780A0 (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE60039274D1 (de) Negativ arbeitende Resistzusammensetzung
DE19983627T1 (de) Knoblauch-Formulierungen mit kontrollierter Freisetzung
EP1073419A4 (en) COMPOSITION, CONTAINING AMORPHOUS POLYMER, FOR DELAYED RELEASE.
DE60215742D1 (de) Schmelzfixiersystem mit Ablagetrommel umfassend eine Trennmitteloberflächenschicht mit kontroliertem Quelleffekt
DK1317256T3 (da) Farmaceutisk sammensætning havende en modificeret bærer
DE60127021D1 (de) Esterverbindungen, Polymere, Photoresistkompositionen und Mustererzeugungsverfahren
EE200000617A (et) Kontrollitud vabanemisega levosimendani peroraalsed koostised